Antimicrobial resistance of shigella isolates in Bangladesh, 1983-1990: Increasing frequency of strains multiply resistant to ampicillin, trimethoprim-sulfamethoxazole, and nalidixic acid

Clinical Infectious Diseases

Volumn 14, Issue 5, 1992, Pages 1055-1060

  Bennish, Michael L ^a,b,c   Salam, Mohammed Abdus ^a,b,c   Hossain, Mohammed Anowar ^a,b,c   Myaux, Jacques ^a,b,c   Khan, Eradul Huq ^a,b,c   Chakraborty, Jyotsnamoy ^a,b,c   Henry, Fitzroy ^a,b,c   Ronsmans, Carine ^a,b,c  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; NALIDIXIC ACID; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BANGLADESH; CONFERENCE PAPER; DRUG USE; FECES CULTURE; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; SHIGELLA;

AMPICILLIN RESISTANCE; BANGLADESH; DIARRHEA; DRUG RESISTANCE, MICROBIAL; DYSENTERY, BACILLARY; FECES; HUMAN; NALIDIXIC ACID; SHIGELLA; SUPPORT, NON-U.S. GOV'T; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0026590254     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/clinids/14.5.1055     Document Type: Article

References (46)

1. Bennish ML, Wojtyniak BJ. Mortality due to shigellosis: community and hospital data. Rev Infect Dis 1991;13(suppl 4):S245-51.
2. Bennish ML, Harris JR, Wojtyniak BJ, Struelens M. Death in shigellosis: incidence and risk factors in hospitalized patients. J Infect Dis 1990;161:500-6.
3. Committee on Issues and Priorities for New Vaccine Development. The burden of disease resulting from diarrhea. In: Katz SL, ed. New vaccine development: establishing priorities. Vol 2. Diseases of importance in developing countries. Washington, DC: National Academy Press, 1986; 165.
4. Salam MA, Bennish ML. Antimicrobial therapy for shigellosis. Rev Infect Dis 1991;13(suppl 4):S332-41.
5. Haltalin KC, Nelson JD, Ring R III, Sladoje M, Hinton LV. Doubleblind treatment study of shigellosis comparing ampicillin, sulfadiazine, and placebo. J Pediatr 1967;70:970-81.
6. Salam MA, Bennish ML. Therapy for shigellosis. 1. Randomized double-blind trial of nalidixic acid in childhood shigellosis. J Pediatr 1988;113:901-7.
7. Anderson DEW, Cruickshank R, Walker J. The treatment of bacillary (Flexner) dysentery with sulphanilylguanidine. BMJ 1941;2:497-501.
8. Cooper ML, Zucker RL, Wagoner S. Sulfathiazole for acute diarrhea and dysentery of infants and children. JAMA 1941; 117:1520-3.
9. Marberg K, Altmann G, Eshkol-Bruck A. Observations on resistance to sulfadiazine and antibiotics in shigellosis. Am J Trop Med Hyg 1958;7:51-7.
10. Weissman JB, Gangarosa EJ, DuPont HL. Changing needs in the antimicrobial therapy of shigellosis. J Infect Dis 1973; 127:611-3.
11. Nelson JD, Kusmiesz H, Jackson LH, Woodman E. Trimethoprim-sulfamethoxazole therapy for shigellosis. JAMA 1976;235:1239-43.
12. Chang MJ, Dunkle LM, Van Reken D, Anderson D, Wong ML, Feigin RD. Trimethoprim-sulfamethoxazole compared to ampicillin in the treatment of shigellosis. Pediatrics 1977;59:726-9.
13. Yunus M, Rahman ASMM, Farooque ASG, Glass RI. Clinical trial of ampicillin v. trimethoprim-sulphamethoxazole in the treatment of Shigella dysentery. J Trop Med Hyg 1982;85:195-9.
14. Pal SC. Epidemic bacillary dysentery in West Bengal, India, 1984 [letter]. Lancet 1984; 1:1462.
15. Bennish M, Eusof A, Kay B, Wierzba T. Multiresistant Shigella infections in Bangladesh [letter]. Lancet 1985;2:441.
16. Lolekha S, Vibulbandhitkit S, Poonyarit P. Response to antimicrobial therapy for shigellosis in Thailand. Rev Infect Dis 1991;13(suppl 4):S342-6.
17. Frost JA, Willshaw GA, Barclay EA, Rowe B, Lemmens P, Vandepitte J. Plasmid characterization of drug-resistant Shigella dysenteriae 1 from an epidemic in Central Africa. J Hyg 1985;94:163-72.
18. Centers for Disease Control. Multiply resistant shigellosis in a day-care center-Texas. MMWR 1986;35:753-5.
19. Centers for Disease Control. Nationwide dissemination of multiply resistant Shigella sonnei following a common-source outbreak. MMWR 1987;36:633-4.
20. Centers for Disease Control. Shigella dysenteriae type 1-Guatemala, 1991. MMWR 1991;40:421-8.
21. Bratoeva MP, John JF Jr. Dissemination of trimethoprim-resistant clones of Shigella sonnei in Bulgaria. J Infect Dis 1989; 159:648-53.
22. Bennish ML, Azad AK, Yousefzadeh D. Intestinal obstruction during shigellosis: incidence, clinical features, risk factors and outcome. Gastroenterology 1991;101:626-34.
23. Bauer AW, Kirby WMM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 1966;45:493-6.
24. Lionel NDW, Abeyasekera FJB, Samarasinghe HG, Goonewardena CV, Tawil GS. A comparison of a single dose and a five-day course of tetracycline therapy in bacillary dysentery. J Trop Med Hyg 1969;72:170-2.
25. Shahid NS, Rahaman MM, Haider K, Banu H, Rahman N. Changing pattern of resistant Shiga bacillus (Shigella dysenteriae type 1) and Shigella flexneri in Bangladesh. J Infect Dis 1985; 152:1114-9.
26. Panhotra BR, Desai B, Sharma PL. Nalidixic-acid-resistant Shigella dysenteriae I [letter]. Lancet 1985; 1:1763.
27. Munshi MH, Sack DA, Haider K, Ahmed ZU, Rahaman MM, Morshed MG. Plasmid-mediated resistance to nalidixic acid in Shigella dysenteriae type I. Lancet 1987;2:419-21.
28. Ronald AR, Turck M, Petersdorf RG. A critical evaluation of nalidixic acid in urinary-tract infections. N Engl J Med 1966;275:1081-9.
29. Ronsmans C, Bennish ML, Chakraborty J, Fauveau V. Current practices for treatment of dysentery in rural Bangladesh. Rev Infect Dis 1991; 13(suppl 4):S351-6.
30. Tauxe RV, Puhr ND, Wells JG, Hargrett-Bean N, Plake PA. Antimicrobial resistance of Shigella isolates in the USA: the importance of international travelers. J Infect Dis 1990; 162:1107-11.
31. Heikkila E, Siitonen A, Jahkola M, Fling M, Sundström L, Huovinen P. Increase of trimethoprim resistance among Shigella species, 1975-1988: analysis of resistance mechanisms. J Infect Dis 1990; 161: 1242-8.
32. Ronsmans C, Bennish ML, Wierzba T. Diagnosis and management of dysentery by community health workers. Lancet 1988;2:552-5.
33. Mitra AK, Kabir I, Hossain MA. Pivmecillinam-resistant Shigella dysenteriae type 1 infection in Bangladesh [letter]. Lancet 1990;335: 1461-2.
34. Kabir I, Rahaman MM, Ahmed SM, Akhter SQ, Butler T. Comparative efficacies of pivmecillinam and ampicillin in acute shigellosis. Antimicrob Agents Chemother 1984;25:643-5.
35. Bennish ML, Salam MA, Haider R, Barza M. Therapy for shigellosis. II. Randomized, double-blind comparison of ciprofloxacin and ampicillin. J Infect Dis 1990;162:711-6.
36. Rogerie F, Ott D, Vandepitte J, Verbist L, Lemmens P, Habiyaremye I. Comparison of norfloxacin and nalidixic acid for treatment of dysentery caused by Shigella dysenteriae type 1 in adults. Antimicrob Agents Chemother 1986;29:883-6.
37. De Mol P, Mets T, Lagasse R, Vandepitte J, Mutwewingabo A, Butzler JP. Treatment of bacillary dysentery: a comparison between enoxacin and nalidixic acid. J Antimicrob Chemother 1987;19:695-8.
38. Gotuzzo E, Oberhelman RA, Maguiña C, et al. Comparison of singledose treatment with norfloxacin and standard 5-day treatment with trimethoprim-sulfamethoxazole for acute shigellosis in adults. Antimicrob Agents Chemother 1989;33:1101-4.
39. Keusch GT, Bennish M. Shigella. In: Farthing MJG, Keusch GT, eds. Enteric infection. Mechanisms, manifestations, and management. New York: Raven Press, 1989:265-82.
40. Ciprofloxacin. Med Lett Drugs Ther 1988;30:11-3.
41. Varsano I, Eidlitz-Marcus T, Nussinovitch M, Elian I. Comparative efficacy of ceftriaxone and ampicillin for treatment of severe shigellosis in children. J Pediatr 1991; 118:627-32.
42. Bennish ML. The Bangladesh drug policy: the next step-using good drugs "goodly." Bangladesh J Child Health 1987;11:63-72.
43. Prince A, Neu HC. Beta-lactamase activity in Shigella sonnei. Antimicrob Agents Chemother 1976;9:776-9.
44. Haider K, Chatkaeomorakot A, Kay BA, et al. Trimethoprim resistance gene in Shigella dysenteriae 1 isolates obtained from widely scattered locations of Asia. Epidemiol Infect 1990;104:219-28.
45. Neu HC. Bacterial resistance to fluoroquinolones. Rev Infect Dis 1988;10(suppl l):S57-63.
46. Wolfson JS, Hooper DC. Bacterial resistance to quinolones: mechanisms and clinical importance. Rev Infect Dis 1989; 11(suppl 5):S960-8.